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WS6.5 Experience and satisfaction of patients and parents with
CF services − A nationwide survey in Germany
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Objectives: To assess the patients’ experiences with care provided by staff in CF
centres, we developed a CF-speciﬁc questionnaire in 2009 [1]. After a pilot study
[2], the revised form was used for a nationwide survey.
Methods: 90 CF centres in Germany were invited to participate. Centre staff
collected patient consent forms and sent the patients’ addresses to the Picker
Institute Germany. The 110 items had 3 to 6 response categories, which were
dichotomised to “problem scores” (PS). The ideal score is 0%, indicating no
problem.
Results: 56 CF centres took part in the survey and recruited 1642 adults with CF
and 1205 parents. The response rates were 74% in each group. Factor analysis
revealed 10 different factors covering 70 of the 110 items. Participants reported
the best results for the factors “physiotherapists” (PS 6%) and “physician-patient
relationship” (PS 9%). Factors with the highest problem scores were inpatient
and outpatient “facilities and services”. Items with high PS were “not enough
information on possible side effects of drugs” (PS 49%) and “inadequate support
to meet other patients/families” (PS 46%). For each item and factor, the institutions
received reports of their own results and the mean PS of all participating centres.
The problem scores differed considerably between CF centres.
Conclusion: The CF-speciﬁc patient experience survey identiﬁed areas with higher
and lower patient satisfaction. Centre staff can use the results to augment the quality
of care.
Supported by an educational grant from Mukoviszidose e.V., the German CF
Association.
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Objectives: The UK CF registry states since 2007 over 40% of intravenous
antibiotics administered to children in the UK were delivered by carer(s) at home
(H-IVAT). Carer focus groups reﬂecting on the challenge of living with CF identiﬁed
H-IVAT as the most challenging task they faced. This study was designed to examine
this healthcare task and identify features that impact on carer well being.
Methods: This was a multi centre observational study of carers. At baseline carers
completed a number of psychometric measures including the Beck Depression
Inventory (BDI) and the Parenting Stress Index (PSI), and a bespoke RISK tool to
assess H-IVAT. Phone diaries were collected at one regular care period and one time
period when parents had the addition of H-IVAT to manage to assess the impact of
H-IVAT on family’s daily life.
Results: 129 families from 30 different CF centres across the UK took part in
the study, representing 22% of children who completed H-IVAT 2009−10. Use
of a homecare company (F(1,99) = 15.9 p< 0.001) and use of infusion device(s)
associated with lower BDI scores (F(2,97) = 6.9, p< 0.005). Parenting stress from
“isolation” (r = 0.57) and “carer poor health” (r = 0.58) associated with higher BDI
scores, but not “use of homecare” or “infusion device”. Multivariate analysis found
“use of homecare company”, “isolation” and “carer poor health” explained the
variance in carer BDI scores (r2 = 0.44). Parents slept on average 74 minutes less
during H-IVAT than the regular care period (t = 2.8, df = 18, p = 0.012).
Conclusion: Use of infusion devices and a homecare company associated with
fewer depressive symptoms. On average carers sleep less during H-IVAT.
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Background: The quality of care in the management of cystic ﬁbrosis is dependent
on frequent review, good access to care and prompt attention to merging issues.
Patients may have difﬁculty accessing care because of distance, physical disability or
socio-economic circumstances. The use of video-conferencing digital data storage
and electronic health records (EHR) has the potential to greatly improve care at
minimal cost. We have previously explored attitudes to digital initiatives and found
that those with little or no experience were ambivalent about changing their practice.
Objectives: To evaluate patient ability to adapt to new, digital CF care-delivery
systems.
Methods: This study surveyed (n = 30) well adult CF patients on initiation of
telemedicine, ie after having made the decision to use video-conferencing. The
survey examined the domains of IT use, barriers, attitudes, security, EHR use,
beneﬁts and quality of care, scoring 0−10 for each question on a Borg scale.
Results: We found that older patients had greater security concerns (p = 0.02) and
those with lower FEV1 thought their EHR should be shared widely (p = 0.02) and
could more easily see beneﬁts of using EHRs (p = 0.02). Highest scores were for
inclusiveness of the EHR (9.4) and lowest scores were for the comparative value
of paper records (4.8).
Conclusion: CF patients choosing telemedicine as an option for their care wanted
more information available in compatible EHRs.
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Objectives: Compare the outcomes of patients with cystic ﬁbrosis (CF) admitted
to an intensive care unit (ICU) with hemoptysis vs other indications.
Methods: Retrospective chart review.
Conclusion: Between 2005 and mid 2011, 30 patients had 48 admissions to the
medical ICU at the University of Utah Hospital. Patient outcomes were evaluated
based on the indication for admission, comparing hemoptysis with all other causes.
For patients admitted more than once only the ﬁrst hospitalization was included in
this evaluation. During this time period 8 patients had hemoptysis and 22 individuals
had other disorders (most commonly respiratory failure from an exacerbation).
The hemoptysis group had a median age, BMI, ICU LOS, and hospital LOS
of 25 y, 19.9, 2.5 d, 15 d respectively. The values for the comparison group are
26.3 y, 19.8, 3 d, and 18 d. None of the hemopysis group was intubated vs 9 of 22
(41%) of the comparison group. All of the hemoptysis patients surived to hospital
discharge and were alive one year later without undergoing transplantation. In the
comparison group ICU, hospital, and one year survival were 77%, 73%, and 68%,
respectively. In the comparison group at one year following ICU admission, 50% of
patients had died or undergone transplantation. In conclusion, hemoptysis appears
to have a better prognosis than other conditions resulting in ICU admission. While
the reason is not evident, a hypothesis is that hemoptysis represents focal lung
inﬂammation/injury versus a more generalized lung injury in other conditions.
